Having trouble accessing articles? Reset your cache.

Incentives added to support China’s rollout of centralized procurement

As China begins the nationwide rollout of its centralized procurement program for generics and off-patent originator drugs, the government has released additional guidelines that include incentives to encourage use of the drugs.

In September,

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE